XML 19 R9.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities:    
Net income (loss) $ (74,833) $ 480,219
Adjustment for loss from discontinued operations 433 10,616
Income (loss) from continuing operations (74,400) 490,835
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 427,917 433,521
Asset impairment charge 224,327 0
Amortization of debt discount and debt issuance costs 1,176 798
Provision for bad debt 544 598
Stock-based compensation 25,467 23,472
Loss on investment securities 50,228 0
Gain on sale of assets (27,050) (15,133)
Deferred income tax benefit (25,503) (498,491)
Other 5,356 3,735
Change in assets and liabilities increasing (decreasing) cash:    
Accounts receivable 63,002 (87,508)
Inventories of materials and supplies 1,473 (14,905)
Prepaid expenses and other (9,556) (9,623)
Other noncurrent assets (5,899) 6,105
Accounts payable 276 6,513
Accrued liabilities 8,110 40,668
Deferred income tax liability 11 (2,511)
Other noncurrent liabilities (6,052) (6,496)
Net cash provided by operating activities from continuing operations 659,427 371,578
Net cash used in operating activities from discontinued operations (56) (150)
Net cash provided by operating activities 659,371 371,428
Cash flows from investing activities:    
Capital expenditures (403,570) (322,658)
Purchase of short-term investments (71,852) (52,159)
Payment for acquisition of business, net of cash acquired (2,781) (47,886)
Proceeds from sale of short-term investments 68,015 52,470
Proceeds from asset sales 36,227 28,049
Net cash used in investing activities (373,961) (342,184)
Cash flows from financing activities:    
Dividends paid (235,058) (230,368)
Debt issuance costs paid (3,912) 0
Proceeds from stock option exercises 2,901 5,160
Payments for employee taxes on net settlement of equity awards (6,420) (5,978)
Payment of contingent consideration from acquisition of business 0 (10,625)
Net cash used in financing activities (242,489) (241,811)
Net increase (decrease) in cash and cash equivalents and restricted cash 42,921 (212,567)
Cash and cash equivalents and restricted cash, beginning of period 326,185 560,509
Cash and cash equivalents and restricted cash, end of period 369,106 347,942
Cash paid during the period:    
Interest paid 12,794 11,888
Income tax paid, net 11,213 4,633
Changes in accounts payable and accrued liabilities related to purchases of property, plant and equipment $ 16,279 $ 1,070